UnknownN/AOther

Modifying Virtual Reality Analgesia With Low-Dose Pain Medication

NCT ID

NCT01840774

Target Enrollment

60 participants

Start Date

2013-04

Est. Completion

2014-06

About This Study

The purpose of this study is to determine how pain relief is modified when the investigators combine the Virtual Reality based Snow World game with certain pain medications.

Conditions Studied

Virtual Reality Therapy

Interventions

•Low-dose pain medication (Ketalar) and saline placebo

Eligibility

Age:18 Years - 60 Years

Healthy Volunteers:Yes

View full eligibility criteria

Inclusion Criteria:

* Healthy male and females between the age of 18 and 60 years
* Ability to communicate orally
* Ability to read and understand English
* Body Mass Index between 20-35

Exclusion Criteria:

* Women who are pregnant, trying to become pregnant, or who are breastfeeding
* History of alcohol or substance abuse
* Major medical illness; including history of migraine headaches, seizures, brain injury, or peripheral neuropathy
* Current use of analgesics including acetaminophen, non-steroidal anti-inflammatories, or opioids
* Predisposition to severe motion sickness
* Unusual sensitivity or lack of sensitivity to pain
* Urine toxicology positive for opioids or benzodiazepines

Study Locations (1)

University of Washington

Seattle, Washington, United States